Stocks
Guardant Health (GH) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 405.4% | 277.2% | 350.8% | 482.6% | 1 792% | 1 696% | |||
| Changes by years, y/y, % | +154pp | -128pp | +74pp | +132pp | +1 310pp | +48.2% | |||
Guardant Health. R&D/CAPEX, %
Guardant Health. R&D/CAPEX, changes, pp
Guardant Health (GH) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 3 957% | 2 204% | 1 209% | 1 637% | 2 079% | 1 696% | ||
| Changes by years, y/y, % | +3 496pp | +1 138pp | -29pp | +249pp | -1 877pp | |||
| Changes by quarters, q/q, % | +2 569pp | -1 753pp | -995pp | +428pp | +442pp | |||
